New funding awards - February 2021

Monday, March 22, 2021

Sponsored Research

Gary Felker of Cardiology has received a sub-award (1R21-HL152148-01) through the University of Pennsylvania for a project entitled "The Feasibility of a Biomarker Guided Strategy in Anthracycline Cardiotoxicity." Total funding will be $19,164.

William Jones of Cardiology has received a sub-award (RI-CRN-2020-009) through the Vanderbilt University Medical Center for a project entitled "Advancement of PCORnet Infrastructure: Clinical Research Network Project - COVID supplement." Total funding will be $28,000.

Jacquelyn Walejko (Mentor: Phillip White) of Endocrinology has received an award from the American Diabetes Association for a project entitled "Reshaping Liver Branched-Chain Alpha-Keto Acid Metabolism to Prevent Diabetic Cardiomyopathy." Total funding will be $50,760.

Rowena Dolor of General Internal Medicine has received a sub-award (1OT2HL156812-01) through the University of Pittsburgh for a project entitled "ACTIV-4B Outpatient Platform." Total funding will be $237,500.

Rowena Dolor of General Internal Medicine has received a sub-award (1OT2HL156812-01) through the University of Pittsburgh for a project entitled "ACTIV-4B Outpatient Platform." Total funding will be $68,897.

Mitchell Horwitz of Hematologic Malignancies and Cellular Therapy has received a sub-award () through the National Marrow Donor Program for a project entitled "CTN1705- Same Day Processing and Storage of Stool Samples for Stool AAT Concentrations, Microbiome and Metabolome studies." Total funding will be $2,701.

Sonali Advani of Infectious Diseases has received an award from the The Society for Healthcare Epidemiology of America for a project entitled "Development of validated diagnostic stewardship strategy to improve reflex urine culture utilization and diagnosis of urinary tract infections." Total funding will be $30,000.

Michael Hauser of Medical Genetics has received an award from the BrightFocus Foundation for a project entitled "Single nuclear RNAseq to characterize glaucoma risk genes." Total funding will be $200,000.

Arif Kamal of Medical Oncology has received an award from the Palliative Care Quality Collaborative for a project entitled "Implementing a Strategic Plan to Collect Quality and Research -Ready Data in Palliative Care." Total funding will be $34,030.

Kevin Oeffinger of Medical Oncology has received a sub-award (1R01-CA237369-01A1) through the University of Chicago for a project entitled "Improving Delivery of Genetic Services to High Risk Childhood Cancer Survivors: A Randomized Study of Remote Genetic Services Versus Usual Care." Total funding will be $14,532.

Linda Sutton of Medical Oncology has received an award from the V Foundation for Cancer Research for a project entitled "Advancing Cancer Care in the Rural Southeast: Enhancing Precision Medicine and Institutional Collaboration in Community Cancer Centers." Total funding will be $75,000.

Scott Palmer of Pulmonary has received an award (75D30120P08974-CLIN0001) from the Centers for Disease Control and Prevention for a project entitled "Understanding Long-term Respiratory Morbidity in Former Styrene-Exposed Workers." Total funding will be $60,000.

Scott Palmer of Pulmonary has received an award (75D30120P08974-CLIN0002) from the Centers for Disease Control and Prevention for a project entitled "Understanding Long-term Respiratory Morbidity in Former Styrene-Exposed Workers." Total funding will be $60,000.

Laurie Snyder of Pulmonary has received a sub-award () through the University of New Hampshire for a project entitled "Cystic Fibrosis Lung Transplant and Transition Regional Dissemination Network - Mini-Grant for Continued Quality Improvement." Total funding will be $2,240.

Kim Huffman of Rheumatology has received an award (1R33-AG070455-01) from the National Institute on Aging for a project entitled "ENHANCING THE CALERIE NETWORK TO ADVANCE AGING BIOLOGY." Total funding will be $3,296,508.

William St. Clair of Rheumatology has received a sub-award (UM1-AI109565-08) through the Benaroya Research Institute at Virginia Mason for a project entitled "Subaward Agreement - Benaroya to Duke - ITN Network Deputy Director of Clinical Affairs FY21-27." Total funding will be $161,064.

Industry-sponsored Clinical Trials

William Herzog of Cardiology has received an award from Golden Biotechnologies Corporation for a project entitled "A Phase 2 Randomized, Double-blind, Placebo-controlled, Proof of Concept Study to Evaluate the Safety and Efficacy of Antroquinonol in Hospitalized Patients with Mild to Moderate Pneumonia due to COVID-19." Total funding will be $207,296.

William Jones of Cardiology has received an award from Boehringer Ingelheim Corporation for a project entitled "EMPACT-MI: A streamlined, multicenter, randomized, parallel group, double-blind placebo-controlled superiority trial to evaluate the effect of EMPAgliflozin on hospitalization for heart failure and mortality in patients with aCuTe Myocardial Infarct." Total funding will be $264,299.

William Jones of Cardiology has received an award from Medtronic, Inc. for a project entitled "ICC Fellow Education Fund." Total funding will be $15,000.

Michel Khouri of Cardiology has received an award from Alnylam Pharmaceuticals for a project entitled "CHEPRI: Chronology of Effects of Patisiran on Cardiac Amyloidosis." Total funding will be $500,961.

Julius Wilder of Gastroenterology has received an award from Mirum Pharmaceuticals, Inc. for a project entitled "A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients with Primary Sclerosing Cholangitis (VISTAS)." Total funding will be $132,349.

Taewoong Choi of Hematologic Malignancies and Cellular Therapy has received an award from Celgene Corporation for a project entitled "Long Term Follow-up Protocol for Subjects Treated with Gene-Modified T Cells." Total funding will be $77,911.

Harry Erba of Hematologic Malignancies and Cellular Therapy has received an award from Kura Oncology for a project entitled "A Phase 1/2A First in Human Study of the Menin-MLL(KMT2A) Inhibitor KO-539 in Patients with Relapsed or Refractory Acute Myeloid Leukemia." Total funding will be $240,230.

Momen Wahidi of Pulmonary has received an award from Veracyte, Inc. for a project entitled "NOBLE: Nose brushings for lung cancer assessment in epithelium." Total funding will be $958,142.